With the significant reduction in IE with current antibiotic regimens, glaucoma is now the most significant threat to vision in KPro patients. The reported incidence of glaucoma preoperatively in KPro eyes is 60-76% and postoperative high IOP has been shown in 15-38% of KPro eyes.

The Boston KPro is a treatment option for corneal disorders not amenable to standard penetrating keratoplasty (corneal transplantation) or corneal transplant.

2017年6月1日 · It is implanted as a treatment for many severe, recalcitrant corneal disorders that are not amenable to traditional corneal transplantation such as penetrating ker­atoplasty (PK).

Keratoprotheses are made of clear plastic with excellent tissue tolerance and optical properties. They vary in design, size and even the implantation techniques may differ across different treatment centers. The procedure is done by ophthalmologists, often on an outpatient basis.

The CorNeat KPro is a patented synthetic cornea that provides a lasting solution for corneal blindness. It enables immediate vision rehabilitation after a straightforward implantation procedure.

2016年4月8日 · Keratoprosthesis implantation is a procedure that involves full-thickness removal of the cornea and replacement by an artificial cornea. The Boston Type I Keratoprosthesis is currently the most commonly used keratoprosthesis device in the US.

Since achieving FDA status in 1992, the Boston KPro has undergone continuous design innovations that have significantly improved the safety and long-term success of the implant. Today, the Boston KPro is the most commonly used corneal prosthesis in the world with more than 11,000 implantations to date in 66 countries by 598 surgeons.

2021年4月1日 · K eratoprosthesis (KPro) is ideal for corneas that have extensive areas of vascularization, and/or have had multiple previous transplant failures, limbal stem cell deficiencies with or without cicatrizing conjunctivitis in the setting of …

The Boston Type 2 Keratoprosthesis (KPro) is an artificial device used to replace the cornea in the setting of diseases with severe, recurrent scarring in which other types of corneal transplants are not a viable option.

Advances in postoperative care have greatly improved the clinical success of the Boston KPro. Common complications such as inflammation and infection are significantly lower with today’s prophylactic drug regimens. Innovative devices have also …